NCT05973071

Brief Summary

The study at hand aims to examine whether incorporating use of a contraceptive decision aid (Tuune for Clinics) improves outcomes for patients seeking contraceptive care. To achieve this the investigators will test: the hypothesis that use of the Tuune decision aid in contraceptive care appointments will: (a) improve patient satisfaction, (b) increase patient positivity toward contraceptive use, and (c) improve patient outcomes, including: (ci) greater adherence to their prescribed contraceptive and (cii) fewer negative side-effects, relative to that which is observed for patients receiving a contraceptive recommendation from a traditional contraceptive counseling appointment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 15, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 2, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

August 2, 2023

Status Verified

July 1, 2023

Enrollment Period

1.5 years

First QC Date

June 15, 2023

Last Update Submit

July 31, 2023

Conditions

Keywords

Decision Aid

Outcome Measures

Primary Outcomes (5)

  • Patient Satisfaction & Appointment Evaluation [1]

    This scale measures patient satisfaction with a contraceptive counseling appointment. Items include "Overall, I was satisfied with the birth control counselling," and "The session helped to strengthen my confidence in my method of birth control." Scale values range from 1 = Strongly agree to 7 = Strongly disagree. Item 10 needs to be reverse coded (R). An overall score can be created for this measure by averaging items. All items could not be pasted in this description box due to character limit. The full list of items is available at https://osf.io/3hdm6/.

    Administered at immediate follow-up.

  • Patient Satisfaction [2]

    This single item measures patient satisfaction with the birth control services received from healthcare providers. Scoring Instructions: Scale values range from 1 = Not at all satisfied to 7 = Extremely satisfied. 1\. In general, how satisfied or dissatisfied would you say you are with the birth control services you have received from healthcare providers?

    Administered at immediate follow-up.

  • Person Centered Contraceptive Counseling (PCCC) [3]

    This measure is an evaluation of whether the physician provided person-centered contraceptive counseling. Scoring Instructions: An overall score can be created for this measure by averaging items. Scale values range from 1 = Poor to 4 = Very good. No items need to be reverse coded. Think about your visit. How do you think \[provider name\] did? Please rate them on each of the following by circling a number (1 = Poor, 2 = Fair, 3 = Good, 4 = Very good). 1. Respecting me as a person. 2. Letting me say what mattered to me about my birth control method. 3. Taking my preferences about my birth control seriously. 4. Giving me enough information to make the best decision about my birth control method.

    Administered at immediate follow-up.

  • Positivity Toward Their Prescribed Medication [4]

    This scale measures patient positivity toward the prescribed medication. Scoring Instructions: An overall score can be created for this measure by averaging items. Scale values range from 1 = Not at all to 7 = Extremely. Item 2 needs to be reverse coded (R). 1. How positively do you feel about this medication? 2. How negatively do you feel about this medication? (R)

    Administered at immediate follow-up

  • Contraceptive Use Expectations [4]

    This scale measures the patient's perceived likelihood that they will take the prescribed medication. Scoring Instructions: Scale values range from 1 = Not at all to 7 = Extremely. 1.How likely are you to take this medication?

    Administered at immediate follow-up

Secondary Outcomes (5)

  • Post-Appointment Contraceptive Adherence [5,6]

    Administered at 3 month digital follow-up

  • Positivity Toward Their Prescribed Medication [4]

    Administered at 3 month digital follow-up

  • Patient Experiences with their Birth Control

    Administered at 3 month digital follow-up.

  • Patient Experiences with their Birth Control - Side Effects

    Administered at 3 month digital follow-up.

  • Post Appointment Contraceptive Use

    Administered at 3 month digital follow-up.

Study Arms (2)

Tuune

EXPERIMENTAL

Participants complete the Tuune contraceptive decision aid health questionnaire as part of their standard OBGYN clinic appointment.

Behavioral: Tuune Supplemented Contraceptive Visit

Control

ACTIVE COMPARATOR

Participants will complete a standard OBGYN clinic appointment without using the Tuune contraceptive decision aid health questionnaire.

Behavioral: Traditional Contraceptive Visit

Interventions

Participants complete the Tuune contraceptive decision aid health questionnaire (Tuune for clinics) as part of their standard OBGYN clinic appointment.

Tuune

Participants will complete a standard OBGYN clinic appointment without using the Tuune contraceptive decision aid health questionnaire (Tuune for Clinics).

Control

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • New or existing patients at Oklahoma State University OBGYN seeking contraceptive counseling.
  • Native Speakers of English.

You may not qualify if:

  • Women who are currently pregnant or breastfeeding
  • Women who wish to become pregnant within the next 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Texas Christian University

Fort Worth, Texas, 76129, United States

Location

Related Publications (6)

  • Bitzer J, Oppelt PG, Deten A. Evaluation of a patient-centred, needs-based approach to support shared decision making in contraceptive counselling: the COCO study. Eur J Contracept Reprod Health Care. 2021 Aug;26(4):326-333. doi: 10.1080/13625187.2021.1908539. Epub 2021 Apr 19.

    PMID: 33871288BACKGROUND
  • Oakley LP, Harvey SM, Lopez-Cevallos DF. Racial and Ethnic Discrimination, Medical Mistrust, and Satisfaction with Birth Control Services among Young Adult Latinas. Womens Health Issues. 2018 Jul-Aug;28(4):313-320. doi: 10.1016/j.whi.2018.03.007. Epub 2018 May 2.

    PMID: 29729838BACKGROUND
  • Dehlendorf C, Fox E, Silverstein IA, Hoffman A, Campora Perez MP, Holt K, Reed R, Hessler D. Development of the Person-Centered Contraceptive Counseling scale (PCCC), a short form of the Interpersonal Quality of Family Planning care scale. Contraception. 2021 May;103(5):310-315. doi: 10.1016/j.contraception.2021.01.008. Epub 2021 Jan 27.

    PMID: 33508252BACKGROUND
  • Minton AR, Young NA, Nievera MA, Mikels JA. Positivity helps the medicine go down: Leveraging framing and affective contexts to enhance the likelihood to take medications. Emotion. 2021 Aug;21(5):1062-1073. doi: 10.1037/emo0000798. Epub 2020 Nov 12.

    PMID: 33180530BACKGROUND
  • Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008 May;10(5):348-54. doi: 10.1111/j.1751-7176.2008.07572.x.

    PMID: 18453793BACKGROUND
  • Tomaszewski D, Aronson BD, Kading M, Morisky D. Relationship between self-efficacy and patient knowledge on adherence to oral contraceptives using the Morisky Medication Adherence Scale (MMAS-8). Reprod Health. 2017 Sep 6;14(1):110. doi: 10.1186/s12978-017-0374-6.

    PMID: 28874178BACKGROUND

MeSH Terms

Conditions

Contraception Behavior

Condition Hierarchy (Ancestors)

Reproductive BehaviorBehavior

Study Officials

  • Sarah E Hill, PhD

    Texas Christian University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sarah E Hill, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
All data will be analyzed by a blind coding process, meaning that the researcher performing the analyses will be unaware of our research hypotheses. All date and timestamp information will also be removed to ensure that those analyzing the data cannot infer which patients were in the Tuune condition and which received a traditional patient appointment.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be block assigned to either the Tuune condition or the traditional contraceptive counseling condition.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 15, 2023

First Posted

August 2, 2023

Study Start

January 1, 2024

Primary Completion

June 30, 2025

Study Completion

December 30, 2025

Last Updated

August 2, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations